Piramidal
Bridge in-vivo with in-silico intelligence.
Piramidal is a neuroscience-focused startup that combines real-world (in-vivo) patient data with computational (in-silico) modeling to advance brain and neurological research. The company has raised a $6M seed round led by Y Combinator and is backed by advisors from top institutions including Stanford, Cleveland Clinic, and King's College London. It appears to be building AI-driven tools for clinical neuroscience applications such as epilepsy.
Piramidal integrates in-vivo patient data with in-silico intelligence to generate actionable neurological insights.
Neurologists and clinical neuroscience researchers
Background.
- Status
- unknown
- Business model
- unknown
- Company
- Piramidal Inc.
Founders
- Dimitris Fotis Sakellariou
- Kris Pahuja
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.